Levels of glial cell-derived inflammatory mediator YKL-40 (Chitinase 3-like 1) have been shown to be elevated in the CSF of both FTLD and AD patients compared to controls (Janelidze et al., 2016; Alcolea et al., 2017). Here, CHI3L1 is linked to Alzheimer disease.